Clinical trial
Federal Cardiomonitoring System. Determination of the Efficiency of a Single-lead ECG Recorded with CardioQVARK Cardiac Monitor in Order to Detect Atrial Fibrillation in Primary Health Centers.
NCT04204330 is registered in ClinicalTrials.gov with I.M. Sechenov First Moscow State Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Federal Cardiomonitoring System. Determination of the Efficiency of a Single-lead ECG Recorded with CardioQVARK Cardiac Monitor in Order to Detect Atrial Fibrillation in Primary Health Centers.
- Lead sponsor
- I.M. Sechenov First Moscow State Medical University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 4, 2019
- Completion date
- October 3, 2024
- Enrollment
- 5,000 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.